申请人:American Home Products Corporation
公开号:US06001867A1
公开(公告)日:1999-12-14
This invention provides compounds of Formula I having the structure ##STR1## wherein: B and D are each, independently, hydrogen, halogen, --CN, alkyl of 1-6 carbon atoms, aryl, aralkyl of 6-12 carbon atoms; X is H, or halogen; R.sup.1 is hydrogen, alkyl of 1-6 carbon atoms, --CH(R.sup.2)W, --C(CH.sub.3).sub.2 CO.sub.2 R.sup.3, 5-thiazolidine-2,4-dione, --CH(R.sup.4)CH.sub.2 CO.sub.2 R.sup.3, --COR.sup.3, or --PO.sub.3 (R.sup.3).sub.2 ; R.sup.2 is hydrogen, alkyl of 1-6 carbon atoms, aralkyl of 6-12 carbon atoms, aryl, --CH.sub.2 (1H-imidazol-4-yl), --CH.sub.2 (3-1H-indolyl), --CH.sub.2 CH.sub.2 (1,3-dioxo-1,3-dihydro-isoindol-2-yl), --CH.sub.2 CH.sub.2 (1-oxo-1,3-dihydro-isoindol-2-yl), or --CH.sub.2 (3-pyridyl); W is --CO.sub.2 R.sup.3, --CONH.sub.2, --CONHOH, --CN, --CONH(CH.sub.2).sub.2 CN, 5-tetrazole, or --PO.sub.3 (R.sup.3).sub.2 ; R.sup.3 is hydrogen, alkyl of 1-6 carbon atoms, or aryl; R.sup.4 is hydrogen, or alkyl of 1-6 carbon atoms; n is 0-2; or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.
该发明提供了具有以下结构的I型化合物:##STR1## 其中:B和D各自独立地为氢、卤素、--CN、1-6个碳原子的烷基、芳基、6-12个碳原子的芳基烷基;X为H或卤素;R1为氢、1-6个碳原子的烷基、--CH(R2)W、--C(CH3)2CO2R3、5-噻唑烷-2,4-二酮、--CH(R4)CH2CO2R3、--COR3或--PO3(R3)2;R2为氢、1-6个碳原子的烷基、6-12个碳原子的芳基烷基、芳基、--CH2(1H-咪唑-4-基)、--CH2(3-1H-吲哚基)、--CH2CH2(1,3-二氢-异吲哚-2-基)、--CH2CH2(1-氧代-1,3-二氢-异吲哚-2-基)或--CH2(3-吡啶基);W为--CO2R3、--CONH2、--CONHOH、--CN、--CONH(CH2)2CN、5-四唑或--PO3(R3)2;R3为氢、1-6个碳原子的烷基或芳基;R4为氢或1-6个碳原子的烷基;n为0-2;或其药学上可接受的盐。该化合物在治疗与胰岛素抵抗或高血糖相关的代谢性疾病方面是有用的。